Queset Medical Offers Filters for Safe Spirometry Including all ndd Models and Midmark and Welch-Allyn Models

Queset Medical, Inc., is a leading distributor of supplies for pulmonary function testing offering a complete line of PFT Anti-Viral filters that comply with recent guidance for spirometry testing during the Corona Virus pandemic.

Queset Medical notes their Anti-Viral Filters meet the recommendations published in reports from the American Thoracic Society, The European Respiratory Society and Canadian Respiratory Society. High-efficiency filters are available for all spirometers including all models of ndd, Midmark, and Welch-Allyn devices.

All filters are FDA approved and provide over 99.99% cross-contamination efficiency for virus control.

Our filtered mouthpieces protect both the patient as well as the test environment. Some spirometers use mouthpieces that are nothing more than hollow tubes. During a spirometry test, the patient is told to exhale as forcefully as possible. This can lead to pathogens being blown around the test environment and onto anyone in the vicinity. Queset’s high-efficiency filters capture these pathogens before they can spread.

Michael J. Boyle, President of SDI Diagnostics, Inc., the manufacturer of the filters, comments that “All filters have been tested and are certified to have passed all requirements of the American Thoracic Society.” He added “they are totally compliant with recent guidelines that state ‘Tests should always be carried out with a high specification disposable in-line bacterial and viral filter in place (We recommend filters with minimum proven efficiency for high expiratory flow of 600 to 700 L/min). Use of disposable combined mouthpieces/sensors is not recommended at this time.’”

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”